Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03080454 · ClinicalTrials.gov registry record · Phase 1
The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke
A Phase 1 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT03080454 is a Phase 1 study that has completed, run by Northwell Health. The registered enrollment target is 26 participants.
The verdict
NCT03080454, a Phase 1 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if 5 consecutive sessions of PathMaker anodal DoubleStim treatment, which combines non-invasive stimulation of the spinal cord (tsDCS- trans-spinal direct current stimulation) and of the median nerve at the peripheral wrist (pDCS-- peripheral direct current stimulation), can significantly reduce spasticity of the wrist and hand after stroke.
Interventions
- DEVICE sham Doublestim
- DEVICE anodal Doublestim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03080454
The ClinicalTrials.gov registry entry for NCT03080454 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sham Doublestim is the first listed.
NCT03080454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03080454 about?
NCT03080454 is a clinical study titled "The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke". The purpose of this study is to evaluate if 5 consecutive sessions of PathMaker anodal DoubleStim treatment, which combines non-invasive stimulation of the spinal cord (tsDCS- trans-spinal direct current stimulation) and of the median nerve at the peripheral wrist (pDCS-- peripheral direct current s...
What is the current status of trial NCT03080454?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2016-09. Estimated completion is 2018-03.
What interventions are being tested in trial NCT03080454?
The interventions under investigation include: sham Doublestim (DEVICE), anodal Doublestim (DEVICE).
Who is sponsoring clinical trial NCT03080454?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.